UnitedHealthcare Approved Her Lupus Treatment—Then Clawed Back $15,000

UnitedHealthcare verified the coverage, authorized Benlysta and paid the claims. Then it changed the coordination of benefits and left a private rheumatology practice with no billable payer.

UnitedHealthcare told us to proceed.

We verified the patient’s benefits. UnitedHealthcare issued prior authorization for Benlysta. GSK’s BENLYSTA Gateway conducted a separate benefits investigation and also identified UnitedHealthcare.

Our private rheumatology practice purchased the medication, administered five infusions, submitted the claims and received payment.

More than a year later, UnitedHealthcare clawed back approximately $15,000.

A clawback is not a denial. The insurer had already adjudicated and paid the claims. UnitedHealthcare reversed those payments and pulled the money back from our practice long after we purchased the medication and treated the patient.

The diagnosis had not changed.

The medical necessity had not changed.

The prior authorization had not changed.

The insurance data changed.

the physician became financially responsible for an insurance system that failed to identify the correct payer before treatment.

The hidden risk of buy-and-bill medicine

Our patient has lupus, a chronic autoimmune disease that can damage the joints, kidneys, skin, blood vessels and other organs. Her physician prescribed intravenous Benlysta, a biologic medication used to treat certain patients with lupus.

Benlysta dosing depends on the patient’s weight. Each infusion can represent thousands of dollars in medication costs.

Under the buy-and-bill model, the physician practice purchases the drug before administering it. The practice carries the acquisition cost, stores the medication, provides the clinical care and then waits for reimbursement.

That model depends on one fundamental expectation: If an insurer verifies coverage, issues prior authorization, processes a clean claim and pays it, the practice should be able to rely on that payment.

In this case, we could not.

The coordination-of-benefits ambush

The patient received UnitedHealthcare coverage as a dependent through her husband.

She later enrolled in an Affordable Care Act plan through Florida Blue because she thought it would supplement her UnitedHealthcare coverage and help with her substantial out-of-pocket responsibility.

Instead, the Florida Blue individual policy became primary because it covered her as the subscriber. UnitedHealthcare became secondary because its plan covered her as a dependent.

She did not purchase supplemental coverage. She unknowingly changed the order in which her insurance companies had to pay.

No one clearly explained that consequence during enrollment.

Why would the Florida Blue or ACA enrollment process allow someone with existing employer-sponsored coverage to purchase another comprehensive policy without clearly warning her that the new plan would become primary?

That is not a minor disclosure. It changes the patient’s network, formulary, prior authorization requirements and financial responsibility. It also changes the insurer the physician must bill first.

The insurance industry created these coordination-of-benefits rules. It should bear responsibility for explaining them.

Every verification missed the same information

Our practice verified UnitedHealthcare coverage.

UnitedHealthcare issued prior authorization.

GSK conducted an independent benefits investigation.

We checked eligibility through Availity.

None of those processes identified Florida Blue as the primary insurer before treatment.

UnitedHealthcare authorized Benlysta, adjudicated the claims and paid our practice.

The system surfaced the Florida Blue policy only after the treatment occurred and the ordinary filing and authorization windows had closed.

UnitedHealthcare then reclassified itself as secondary and clawed back its payments.

We attempted to bill Florida Blue, but Florida Blue would not provide retroactive authorization for infusions administered many months earlier. We do not even know whether Benlysta met that plan’s formulary requirements at the time of treatment.

UnitedHealthcare says Florida Blue should have paid first.

Florida Blue says we did not obtain its prior authorization.

GSK says its benefits investigation reflected the information available at the time.

The patient stopped treatment and no longer responds to our telephone calls or letters.

Our practice was told to pursue the patient for the money.

Every entity preserved its defense. Only the physician practice retained the financial loss.

UnitedHealthcare can reach backward. The physician cannot.

UnitedHealthcare’s provider guide describes procedures for disputing recoupments and correcting claims affected by retroactive eligibility changes.

We tried.

We were told that too much time had passed to obtain authorization or bill the correct primary insurer.

Consider the contradiction.

UnitedHealthcare relied on information discovered months later to reverse claims it had already authorized, adjudicated and paid. But when we tried to correct those claims using the same newly discovered information, the insurers relied on timely filing and prior authorization rules to block payment.

UnitedHealthcare could reach backward to recover its money.

Florida Blue could reject the claims because we could not travel backward and obtain its authorization.

The physician could do neither.

This is not a functional appeals process. It is an administrative trap with only one party left exposed.

The technology worked. The information did not.

Availity reports that its network connects approximately 2 million providers, health plans and technology partners and processes more than 13 billion clinical, administrative and financial transactions annually.

Yet the eligibility information available to our practice did not reveal the insurance policy that UnitedHealthcare later used to justify the clawback.

CAQH reports that 96% of medical eligibility and benefits transactions occur electronically. It also identifies an additional $11.7 billion in potential savings from improving those transactions.

The industry has largely automated eligibility verification. It has not guaranteed that the information returned is complete or reliable.

Electronic verification can produce an answer in seconds. That speed means little if an insurer can revise the answer months later and transfer the financial consequences to the provider.

Prior authorization already consumes enormous resources

According to the American Medical Association, physicians complete an average of 43 prior authorizations each week. Those requests consume approximately 12 hours of physician and staff time.

Ninety-four percent of physicians report that prior authorization delays necessary care.

Physicians tolerate this burden because insurers require it before treatment. But what protection does prior authorization offer if the insurer can approve the treatment, pay the claim and revoke the financial commitment nearly a year to more than a year later?

The latest available federal claims data reveal the broader problem. A 2026 KFF analysis found that HealthCare.gov insurers denied 19% of in-network claims in 2024—approximately 85 million claims. Administrative issues accounted for 25% of reported denial reasons.

Consumers appealed fewer than 1% of denied claims. Insurers upheld 66% of the denials that patients did appeal.

This is not an occasional paperwork failure. Administrative complexity determines who receives care, who gets paid and who absorbs the loss.

Do not make the patient the scapegoat

Yes, the patient had a responsibility to disclose every insurance policy.

But disclosure alone does not explain this failure.

Our billing professionals did not identify the correct payer. UnitedHealthcare did not identify it. Florida Blue did not coordinate it. Availity did not display it. GSK’s benefits investigation did not uncover it.

If the organizations that write the rules, administer the plans and exchange the data could not determine the correct payer before treatment, why do we expect a patient to understand the consequences better than they did?

This system is intentionally complex. Patients routinely confuse primary coverage, secondary coverage, supplemental insurance, coordination of benefits, deductibles, coinsurance and out-of-pocket maximums.

The patient thought she was purchasing more protection.

Instead, she lost access to treatment and may now face a bill for approximately $15,000. The physician treated her based on verified information and prior authorization.

Instead, the practice financed the medication and inherited the loss.

The insurers protected themselves.

Prior authorization must create financial reliance

Once an insurer verifies eligibility, issues prior authorization, adjudicates a clean claim and pays it, the insurer should not be permitted to claw back that payment because it discovers another policy months later.

The insurers should reconcile the payment among themselves.

If Florida Blue should have been primary, UnitedHealthcare should pursue reimbursement directly from Florida Blue—or, when legally appropriate, from the member who failed to disclose the coverage.

UnitedHealthcare should not turn the physician into its banker and collection agency after every opportunity to bill the correct insurer has expired.

Healthcare needs a clear provider safe harbor:

• Documented eligibility verification and prior authorization should protect a provider from a later coordination-of-benefits clawback.

• Insurers should resolve retroactive COB disputes directly with one another.

• If a clawback remains permissible, the newly identified primary insurer must waive timely filing and retroactive authorization requirements.

• Eligibility systems must disclose all known coverage before treatment.

• ACA plans must warn consumers when enrollment will change the order of their existing insurance.

• Insurers should not shift the loss to patients or physicians when their own information systems failed.

Without those protections, prior authorization is not authorization.

Benefits verification is not verification.

Payment is not payment.

It is a temporary opinion that an insurer can reverse after everyone else loses the ability to correct it.

UnitedHealthcare authorized the treatment. We purchased the Benlysta. We treated the patient. UnitedHealthcare paid the claims.

Then it changed the answer and clawed back approximately $15,000.

Florida Blue refused retroactive authorization. The patient stopped treatment. Our private practice inherited the bill.

That is not coordination of benefits.

That is coordination of blame.